Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?
Alexander J Thompson, John G McHutchison
Hepatology | WILEY | Published : 2012
Related Projects (1)
A.J.T and J.G.M are coinventors of a patent related to the IL28B discovery. A.J.T has received research support from Merck, Roche and Gilead Sciences, has served as a consultant for Merck, Roche and Janssen-Cilag, and has served on speaker bureaus for Merck. J.G.M. is an employee of Gilead Sciences.